Suchergebnisse - "Gavura, Scott"

PubPharm (48)

1

Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada : a cross-sectional study

enthalten in: The Lancet. Oncology | 2024

von Del Paggio, J. | Naipaul, R. | Gavura, S. | +5

2

Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management : Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration

enthalten in: Current oncology (Toronto, Ont.) | 2024

von Takhar, P. | Geirnaert, M. | Gavura, S. | +19

3

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer

enthalten in: Current oncology (Toronto, Ont.) | 2024

von Muñoz, C. | Tai, X. | Arias, J. | +4

4

Cost-effectiveness of second-line ipilimumab for metastatic melanoma : A real-world population-based cohort study of resource utilization

enthalten in: Cancer medicine | 2023

von Lu, B. | Dai, W. | Croxford, R. | +10

5

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Parmar, A. | Dai, W. | Dionne, F. | +23

6

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma : A real‐world population‐based cohort study of resource utilization

enthalten in: Cancer Medicine | 2023

von Lu, B. | Dai, W. | Croxford, R. | +10

7

Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada

enthalten in: JAMA network open | 2022

von Habbous, S. | Tai, X. | Beca, J. | +19

8

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

enthalten in: ResearchSquare.com | 2022

von Dai, W. | Beca, J. | Croxford, R. | +8

9

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

enthalten in: ResearchSquare.com | 2022

von Dai, W. | Beca, J. | Croxford, R. | +8

10

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer

enthalten in: JNCI cancer spectrum | 2022

von Arciero, V. | Luo, J. | Parmar, A. | +12

1
2
3
4
5
Nächster »
[5]